Entrada Therapeutics
TRDA
TRDA
55 hedge funds and large institutions have $411M invested in Entrada Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 56 → 55 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
55
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$1.8M | |
| 2 | +$975K | |
| 3 | +$942K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$600K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$413K |
Top Sellers
| 1 | -$436K | |
| 2 | -$277K | |
| 3 | -$219K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$171K |
| 5 |
Morgan Stanley
New York
|
-$142K |